Asia Pacific HIV Diagnostics Market to Surpass US$ 1,333.4 MN by 2030

April 30, 2020 — Global HIV Diagnostics Market is anticipated to reach USD 4.48 billion by 2022.

The human immunodeficiency virus (HIV) leads to Acquired Immuno Deficiency Syndrome (AIDS).

The factors that propel the growth of the HIV Diagnostics industry include growing number of blood transfusions and blood donations, prevalence of HIV/AIDS worldwide, assistance offered by point-of-care instruments & kits, and growing consciousness about HIV/AIDS and rising administration initiatives.

Get a Free Sample Copy of Report @ https://www.millioninsights.com/industry-reports/hiv-diagnostics-market/request-sample HIV Diagnostics industry may be explored by Product type, end user, test type, and geography.

The market may be explored by product type as Instruments, Software and Services, Consumables, Kits, Assay, and Reagents, and the other Consumables.

The HIV Diagnostics Market Report Provides Growth History, Sales Channel, Manufacturers Profiled in HIV Diagnostics Business, Market Share of Product, Application and Regional Scope of HIV Diagnostics which makes the research report a helpful resource for marketing people, forecasters, industry executives & consultants, sales, product managers, Strategy Advisor, potential investors to understand the present as well as future market size, situations in terms of growth rate and revenue.

Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide.The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021.Market DynamicsDrivers+ Growing Worldwide Prevalence of HIV/Aids+ Increasing Number of Blood Transfusions and Blood Donations+ Benefits Offered By Point-Of-Care Instruments & Kits+ Increasing Government InitiativesRequest for Free Sample Pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=66008285AIDS is a major public health concern with a prevalence rate that has increased dramatically in the past two decades.

This increase in the prevalence of HIV, and the subsequent increase in the number of patients suffering from AIDS, has resulted in an increase in the demand for advanced technologies for HIV diagnostics.According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections.

Globally, 1.1 million people died from HIV-related causes in 2015.

According to the CDC, in 2015, more than 1.2 million people in the U.S. were reportedly infected with HIV, and almost 19% of these were not aware about their status.According to Canada’s source for HIV, the CATIE, in 2014, 75,500 Canadians were found to be HIV-infected, and HIV incidence has increased by 9.7% since 2011.

According to the Robert Koch Institute, there were 84,700 individuals with HIV in Germany in 2016 and more than 3,200 new cases of HIV in 2015.

According to AVERT, in 2015, 5.1 million people were living with HIV/AIDS in Asia, of which only 64% population were aware about their HIV status.

Global HIV Diagnostics Market Research Report, by Product (Consumables, Instruments and Software & Services), Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis and Tests for Viral Identification), End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings and Other) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027Market HighlightsAccording to MRFR analysis, the Global HIV Diagnostics Market is expected to register a CAGR of 10.6% during the forecast period of 2020 to 2027 and is anticipated to reach USD 7,118.26 Million by 2027.The growth of the global HIV diagnostics market is driven by various factors, such as the growing demand for the technologically advanced devices for diagnosing HIV with high accuracy, increasing adaption of home diagnostic kits  for testing of HIV, rising funding for research and development activities to develop new kits.

Additionally, the increasing strategic collaboration, expansion, and product launches by the companies also contributes in the market growth.

However, the ignorance of healthcare issues, lack of awareness about the disease and limited availability of advanced products in the developing countries hamper the market growth.Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to be the largest market owing to the presence of large number of companies providing HIV diagnostics such as Bio-Rad Laboratorie, Becton, Dickinson & Company, Thermo-Fisher Scientific Inc., Abbott Laboratories and many more.

The large number of HIV cases and presence of number of manufacturing companies drives the market growth in this region.

However the increasing healthcare infrastructure and presence of diagnostic centers in this region drives the market growth.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/9757SegmentationGlobal HIV Diagnostics Market has been segmented based on Product, Test Type, and End Users.Global HIV Diagnostics Market has been segmented, on the basis on product, into consumables, instruments and software & services.